Objectives: Iliocaval obstruction is a significant cause of morbidity, with patients suffering spectrum of symptoms including pulmonary embolus, painful lower extremity swelling and recurrent deep venous thrombosis. The aim of our study was to assess the capability of certain magnetic resonance imaging (MRI) sequences to determine age thresholds of experimentally created inferior vena cava (IVC) thrombosis in pigs. Ultimately, the goal is to define MRI as an imaging modality that would allow noninvasive assessment of specific stages of venous remodeling.
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Methods: We developed a totally endovascular swine model of IVC thrombosis combining venous stasis and hypercoagulability, mimicking human physiopathology and preserving the integrity of the venous wall. Animals underwent MRI at baseline, right after thrombosis creation and after a prescribed follow-up period going from 1 to 5 weeks. Animals were divided into 3 groups according to the chronicity of the IVC thrombosis created: group 1 between 0 and 7 days, group 2 between 8 and 29 days, group 3 more than 30 days. The high-resolution T1 vibe 1 mm and modified look-locker inversion recovery (MOLLI) T1 precontrast sequences were used for the analysis. For each animal, we segmented the MRI sequences of two locations in the infrarenal IVC using ImageJ software (rsb.info.nih.gov/ij), and analyzed the T1 times for each thrombus. We then compared the T1-times of each group.
Results: We successfully created IVC thrombosis in 14 female domestic pigs: 2 in group 1, 5 in group 2, and 4 in group 3. Three animals died before the follow-up date. Mean T1 times (6 standard deviation) for each group were respectively 1140.44 6 161.83 ms, 726.54 6 380.83 ms, and 986.03 6 156.55 ms. Kruskal-Wallis test showed a statistically significant difference in T1 times between the three groups of IVC thrombus (c 2 with ties ¼ 7.207 with 2 degrees of freedom; P ¼ .0272).
Conclusions: Our initial results show that T1 times of IVC thrombosis are significantly different in accordance with age of the thrombus; specific MRI sequences might thus be a noninvasive tool to precisely stage the initiation of the disease. Further work will focus on histological analysis of each thrombosed vein to establish correlates in tissue identification between MRI and histology. In addition to providing a better understanding of venous thrombosis remodeling over time, MRI has the potential to be the tool, which may allow us to characterize the content of venous thrombosis over time. This has potential implications for venous pathology therapies.
Author Disclosures: K. Autry: Nothing to disclose; J. Bismuth: Nothing to disclose; G. Brunner: Nothing to disclose; N. Chakfé: Nothing to disclose; L. Magnus: Nothing to disclose; J. Markovits: Nothing to disclose; A. Schwein: Nothing to disclose; D. Shah: Nothing to disclose. Objectives: A novel mechanical device for lower leg intermittent sequential compression was specifically designed to address the limitations of intermittent pneumatic compression (IPC) for the treatment of venous leg ulcers (VLU). The use of intermittent mechanical compression (IMC) allows the delivery of more rapid compression cycles than IPC, which have been show in a randomized trial to improve VLU healing. The device is portable and light-weight, which has the potential to improve compliance by allowing the patient to remain fully mobile during therapy. Finally, the device can monitor compression dose, compliance and response so that more informed therapeutic decisions can be made.
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Augmentation of Peak Venous Velocity in Venous Insufficiency Using a Novel Mechanical Intermittent Sequential Compression Device
Methods: Ten patients with CEAP three to six venous insufficiency were recruited into an IRB approved study of venous flow augmentation. The primary end point for the study was augmentation of venous blood flow as measured by peak venous velocity. Patients who passed a DVT screen went on to have measurement of peak venous velocity in cm/s at the popliteal and femoral veins for the following conditions: (1) baseline (2) novel mechanical device in low setting (3) novel mechanical device in high setting. In 5 patients, an additional measurement of peak venous velocity in cm/s at the popliteal and femoral veins was completed while wearing a commercially available portable intermittent pneumatic compression device. The study was powered for the primary end point at 80% to determine if blood flow could be augmented from 15 cm/s to 30 cm/s with a pretest predicted standard deviation of 8.
Results: Both low and high settings of the IMC device resulted in higher average peak venous velocities when compared with both baseline and the IPC device (P < .05). Figs 1 and 2 show the average popliteal and 
